Biomonitor Iv (471155)
Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection). 510(k) K261074, from Biotronik, Inc. (Lake Oswego, OR). Product code MXD, class 2.
As of Nov 19, 2026, K261074 is an FDA 510(k) held by Biotronik, Inc., substantially equivalent on May 1, 2026 after 30 days, with no recalls tied to it in FDA's recall database.
- Review time: 30 days
- Recalls: 0
21 CFR 807.92(a)(5) The BIOMONITOR IV is indicated to detect the following cardiac arrhythmias: • Atrial fibrillation - Bradycardia - Sudden Rate Drop - Tachycardia - Pause The BIOMONITOR IV is indicated for use in: • Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias • Patients who experience transient symptoms that may suggest a cardiac arrhythmia.
- Biomonitor IvK230375 · Biotronik, Inc. · May 19, 2023
- LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)K262735 · Medtronic, Inc. · Aug 28, 2026
- Assert-IQ (DM5100)K253516 · Abbott Medical · Dec 18, 2025
- Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)K251221 · Abbott · Sep 17, 2025
- LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)K252593 · Boston Scientific Corporation · Sep 12, 2025
- LINQ II™ Insertable Cardiac Monitor (ICM)K240693 · Medtronic, Inc. · Mar 28, 2024
- LINQ II Insertable Cardiac MonitorK233562 · Medtronic, Inc. · Dec 6, 2023
- LINQ II™ Insertable Cardiac Monitor (LNQ22)K233320 · Medtronic, Inc. · Oct 31, 2023
- LUX-Dx II (M302); LUX-Dx II+ (M312)K231328 · Boston Scientific Corp · Aug 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 1, 2026
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files